Report
Quarterly Litigation Status Report-March 2015
Date
File
Quarterly Litigation Status Report (March 2015)
(213.03 KB)
Displaying 1441 - 1460 of 2211
FTC Approves Surgery Center Holdings, Inc.’s Application to Divest Assets in Central Florida to Dr. Mark W. Hollmann
Date
Following a public comment period, the Federal Trade Commission has approved an application from the owners of Surgery Center Holdings, known as Surgery Partners to divest Symbion Holdings Corporation...
Statement by FTC Chairwoman Edith Ramirez on U.S. Supreme Court Ruling Regarding North Carolina Dental Board Matter
Date
“Today, the Supreme Court affirmed the FTC's position in recognizing that a state may not give private market participants unsupervised authority to suppress competition even if they act through a...
FTC Puts Conditions on Novartis AG’s Proposed Acquisition of GlaxoSmithKline’s Oncology Drugs
Date
Global pharmaceutical company Novartis AG has agreed to divest all assets related to its BRAF and MEK inhibitor drugs, currently in development, to Boulder, Colorado-based Array BioPharma to settle...
Boehringer Ingelheim Pharmaceuticals, Inc.
Type of Action
Process Enforcement
Last Updated
FTC Matter/File Number
091 0182
Case Status
Closed
FTC Challenges Proposed Merger of Sysco and US Foods
Date
Agency Charges Merger Would Create a National Broadline Foodservice Distributor With 75 Percent Market Share, and Harm Customers in Numerous Local Markets
FTC, DOJ Announce Agenda for Joint Public Workshop on Examining U.S. Health Care Competition
Date
The Federal Trade Commission and the U.S. Department of Justice’s Antitrust Division have issued an agenda and posted speaker bios for their joint workshop in the series Examining Health Care...
FTC Approves Merck & Co., Inc.’s Application to Sell Facilities for Manufacturing Heartgard and Heartgard Plus Heartworm Treatments for Dogs to Merial
Date
Following a public comment period, the Federal Trade Commission has approved an application for prior approval from Merck & Co., Inc. to sell its Barcelonata facility to Merial Barceloneta LLC, a...
Statement by FTC Chairwoman Edith Ramirez on Appellate Ruling in the St. Luke’s Hospital Matter
Date
The decision affirms the decision by the U.S. District Court in the District of Idaho, which held that the acquisition violated Section 7 of the Clayton Act and the Idaho Competition Act, and ordered...
FTC Submits Fiscal Year 2016 Budget Request, Performance Plan, and Fiscal Year 2014 Performance Report to Congress
Date
The Federal Trade Commission has submitted to Congress its Fiscal Year 2016 budget request, which includes the FY 2016 Budget Overview Statement, Performance Plan for FY 2015 and FY 2016, and...
FTC Puts Conditions on Sun Pharmaceutical’s Proposed Acquisition of Ranbaxy
Date
Pharmaceutical companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. have agreed to divest Ranbaxy’s interests in generic minocycline tablets in order to settle Federal Trade...
FTC Announces Schedule for Reviewing Regulations
Date
As part of the Federal Trade Commission’s systematic review of all current FTC rules and guides, the agency is announcing a modified 10-year regulatory review schedule. To ensure that its rules and...
FTC Requires Albertsons and Safeway to Sell 168 Stores as a Condition of Merger
Date
Supermarket operators Albertsons and Safeway Inc. have agreed to sell 168 supermarkets to settle Federal Trade Commission charges that their proposed $9.2 billion merger would likely be...
FTC Approves Final Order Preserving Future Competition in the Market for Drug-coated Balloon Catheters Used to Treat Peripheral Artery Disease
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that global medical technology company Medtronic, Inc.’s $42.9 billion acquisition of...
FTC Approves Final Order Preserving Competition in the Market for Nicotine Patches
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that global pharmaceutical company Novartis AG’s consumer health care products joint venture...
FTC Announces New Thresholds for Clayton Act Antitrust Reviews for 2015
Date
The Federal Trade Commission has revised the thresholds that determine whether companies are required to notify federal antitrust authorities about a transaction under Section 7A of the Clayton Act...
FTC Approves Modified Final Order for Bi-Lo
Date
The Federal Trade Commission has approved a modified final order settling charges that grocery store operator Bi-Lo Holdings, LLC’s $265 million acquisition of 154 stores from Delhaize America would...
FTC Proposes to Study Merger Remedies
Date
The Federal Trade Commission is seeking public comments on a proposal to study the effectiveness of the Commission’s orders in merger cases where it required a divestiture or other remedy. The study...
FTC Approves Final Order Barring Blue Rhino, AmeriGas from Restraining Competition
Date
Following a public comment period, the Federal Trade Commission has approved final orders settling charges that Blue Rhino and AmeriGas Cylinder Exchange, the two leading suppliers of propane exchange...
FTC Requests Public Comment on Merck & Co., Inc.’s Application to Approve Sale of Facilities for Manufacturing Heartgard and Heartgard Plus Heartworm Treatments for Dogs
Date
The Federal Trade Commission is currently accepting public comments on an application by Merck & Co., Inc. to sell assets and properties in Puerto Rico it uses to manufacture Heartgard and Heartgard...
Displaying 1441 - 1460 of 2211